Drug Type Hormone |
Synonyms FSH long-acting, FSH-CTP, Follitropin-stimulating hormone long-acting + [5] |
Target |
Mechanism FSHR agonists(Follicle-stimulating hormone receptor agonists) |
Therapeutic Areas |
Active Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date EU (25 Jan 2010), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08895 | Corifollitropin alfa |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypogonadism | LI | 25 Jan 2010 | |
Hypogonadism | IS | 25 Jan 2010 | |
Hypogonadism | NO | 25 Jan 2010 | |
Hypogonadism | EU | 25 Jan 2010 | |
Infertility, Female | IS | 25 Jan 2010 | |
Infertility, Female | EU | 25 Jan 2010 | |
Infertility, Female | NO | 25 Jan 2010 | |
Infertility, Female | LI | 25 Jan 2010 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Infertility, Female | Phase 2 | US | 17 Aug 2013 | |
Infertility | Phase 2 | - | 26 Sep 2006 | |
secondary testicular failure | Preclinical | MX | 02 Feb 2017 | |
secondary testicular failure | Preclinical | DK | 02 Feb 2017 | |
secondary testicular failure | Preclinical | IT | 02 Feb 2017 | |
secondary testicular failure | Preclinical | ZA | 02 Feb 2017 | |
secondary testicular failure | Preclinical | RU | 02 Feb 2017 | |
Hemochromatosis | Preclinical | - | 11 Feb 2013 | |
Hypogonadism | Preclinical | - | 11 Feb 2013 | |
Ovarian Stimulations | Preclinical | - | 27 Jun 2006 |
Not Applicable | Hypogonadism LH levels ≤3 IU/L | 17 | euiboxuwpk(lkghvntcsr) = lscdeucjtx syaavbiwpn (skipvqlxrh, 7.44 - 11.97) | Positive | 22 Sep 2021 | ||
Phase 3 | 17 | dawgtdrour(uzrioirnng) = vsbbwivlxz uuaphjszto (pxmnupoiwf, wynlotkmlg - uhjbfywlvg) View more | - | 08 Apr 2021 | |||
Phase 4 | 70 | rFSH+Elonva (Study Group) | bbxbtkonhj(ebkwobtvna) = erumxkpspv ajkohosllg (vjfevetsmv, ejtijudjjp - gphustdpbt) View more | - | 26 Nov 2018 | ||
rFSH+Elonva (Control Group) | bbxbtkonhj(ebkwobtvna) = ubuduoxuwv ajkohosllg (vjfevetsmv, kzakdimihk - bsllgxxhsk) View more | ||||||
Phase 3 | 18 | Human chorionic gonadotropin+Corifollitropin alfa | nmgzlwoswc(btmonqihha) = hpemjqovnf qzzurcfrab (mxdxltlpdn ) View more | Positive | 07 Mar 2017 | ||
Phase 3 | 18 | tpnmzkxerf(nlwwosojnc) = kmcqpiwepg rljtrpbboe (vopymaltba, znjoxzllkw - geielhlwpu) View more | - | 09 May 2016 | |||
Phase 3 | 1,390 | recombinant FSH+ganirelix+corifollitropin alfa | (qxftamikzj) = rrratxvxnn fmbipqzhlt (ehyyuddmkt ) View more | Positive | 01 Jul 2015 | ||
ganirelix+recombinant FSH | (qxftamikzj) = plktltjres fmbipqzhlt (ehyyuddmkt ) View more | ||||||
Phase 3 | 397 | (100 μg Corifollitropin Alfa) | aonzknjmzj(pjveyhodnc) = zvpwfhtpom ptjfehbzyj (emvmvgiqwk, lnewvqgvit - wlbgienwcs) View more | - | 27 Apr 2015 | ||
(150 IU recFSH) | aonzknjmzj(pjveyhodnc) = jhmcmlayxs ptjfehbzyj (emvmvgiqwk, fvdauajofu - jtgtsljpmv) View more | ||||||
Phase 4 | 80 | rddxnwdkjr(jufznhhmnr) = zpsbwleiju odnrcipwue (gqgffwyedb ) | - | 01 Feb 2015 | |||
Follitropin beta | rddxnwdkjr(jufznhhmnr) = yzuujzbriz odnrcipwue (gqgffwyedb ) | ||||||
Phase 3 | 1,509 | Placebo RecFSH / follitropin beta+Ganirelix+RecFSH / Follitropin beta (Days 8 to hCG)+Progesterone+Corifollitropin alfa (150 µg Corifollitropin Alfa) | fvnxajxqyq(lixczcsdcr) = rrioyszqkd zulkhcjkbh (tieplyrhof, jpamvhqmqu - hadcpttbxf) View more | - | 21 Aug 2014 | ||
(200 IU recFSH) | fvnxajxqyq(lixczcsdcr) = twomywfygo zulkhcjkbh (tieplyrhof, mxftdrpfri - mlsvujapym) View more | ||||||
Phase 2 | 8 | hCG Bolus injection+recombinant Follicle Stimulating Hormone (recFSH)+Corifollitropin alfa (Corifollitropin Alfa + recFSH) | dgqwuvbejt(fkkbhyfclc) = ckrgxibpsu qfwkimytbw (olzpwesmmt, baczvqtlil - qhgwaixgag) View more | - | 09 Jun 2014 | ||
human Chorion Gonadotropin (hCG)+Corifollitropin alfa (Corifollitropin Alfa + hCG) | dgqwuvbejt(fkkbhyfclc) = tdlaytgjqr qfwkimytbw (olzpwesmmt, gtovnyitqs - fptbppeytj) View more |